Stein et al., 2007 - Google Patents
Stabilization of hard gelatin capsule shells filled with polyethylene glycol matricesStein et al., 2007
- Document ID
- 6818136920269218648
- Author
- Stein D
- Bindra D
- Publication year
- Publication venue
- Pharmaceutical development and technology
External Links
Snippet
The purpose of this study was to evaluate the effects of various stabilizers on the dissolution stability of liquid-filled capsule dosage forms containing a potent drug dissolved in polyethylene glycols. A systematic dissolution slowdown was observed in gelatin capsule …
- 229920001223 polyethylene glycol 0 title abstract description 77
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Efentakis et al. | Evaluation of high molecular weight poly (oxyethylene)(Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules | |
| Wu et al. | Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials | |
| EP2750600B1 (en) | Fill formulations and capsules and method of use to avoid migration of fill into or through the shell | |
| Pearnchob et al. | Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets | |
| Gupta et al. | Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent | |
| Nur et al. | Captopril floating and/or bioadhesive tablets: design and release kinetics | |
| El Nabarawi et al. | Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl | |
| Citrome | Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability | |
| US20070224261A1 (en) | Eutectic liquid drug formulation | |
| Deng et al. | Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion | |
| Berard et al. | Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion | |
| Yan et al. | Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets | |
| Shephard et al. | Nitrosamine impurities in angiotensin receptor blockers | |
| Stein et al. | Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices | |
| El-Bary et al. | Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an in vitro/in silico study | |
| Mermelstein et al. | Single‐Dose and Multiple‐Dose Pharmacokinetics and Dose Proportionality of Intravenous and Intramuscular HP β CD‐Diclofenac (Dyloject) Compared with Other Diclofenac Formulations | |
| Kovaleski et al. | Impurities in generic pharmaceutical development | |
| Cory et al. | Accelerated degradation of ibuprofen in tablets | |
| WO2019240212A1 (en) | Formulation containing pharmaceutically active ingredient | |
| Galal et al. | Study of In‐Vitro Release Characteristics of Carbamazepine Extended Release Semisolid Matrix Filled Capsules Based on Gelucires | |
| Mahesha et al. | A comprehensive review of green approaches to drug solubility enhancement | |
| Alsaab et al. | Evaluation of the percutaneous absorption of chlorpromazine from PLO gels across porcine ear and human abdominal skin | |
| Wu et al. | Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form | |
| Al-Zein et al. | Effect of packaging and storage on the stability of carbamazepine tablets | |
| Helmschrott et al. | Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen |